Role of functional polymorphism of matrix metalloproteinase-2 (-1306 C/T and -168 G/T) and MMP-9 (-1562 C/T) promoter in oral submucous fibrosis and head and neck squamous cell carcinoma in an Indian population

Biomarkers

Volumn 16, Issue 7, 2011, Pages 577-586

  Chaudhary, Ajay Kumar ^a,b,c   Pandya, Shruti ^b,c   Mehrotra, Ravi ^b   Singh, Mangal ^b   Singh, Mamta ^b  

^a UNIVERSITY OF ALLAHABAD   (India)

^b MLN MEDICAL COLLEGE   (India)

^c TATA MEMORIAL HOSPITAL   (India)

Author keywords

genomics; HNSCC; MMP; OSMF; SNP

Indexed keywords

GELATINASE A; GELATINASE B;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; MOUTH DISEASE; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEAD AND NECK NEOPLASMS; HUMANS; INDIA; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; ODDS RATIO; ORAL SUBMUCOUS FIBROSIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 80054932238     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2011.609602     Document Type: Article

References (59)

1. Barlas IO, Sezgin M, Erdal ME, Sahin G, Ankarali HC, Altintas ZM, Türkmen E. (2009). Association of (-1,607) 1G/2G polymorphism of matrix metalloproteinase-1 gene with knee osteoarthritis in the Turkish population (knee osteoarthritis and MMPs gene polymorphisms). Rheumatol Int 29:383-388.
2. Bayramoglu A, Gunes HV, Metintas M, Degirmenci I, Mutlu F, Alatas F. (2009). The association of MMP-9 enzyme activity, MMP-9 C1562T polymorphism, and MMP-2 and -9 and TIMP-1, -2, -3, and -4 gene expression in lung cancer. Genet Test Mol Biomarkers 13:671-678.
3. Bian J, Sun Y. (1997). Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter. Mol Cell Biol 17:6330-6338. (Pubitemid 27451177)
4. Canniff JP, Harvey W. (1981). The aetiology of oral submucous fibrosis: the stimulation of collagen synthesis by extracts of areca nut. Int J Oral Surg 10:163-167. (Pubitemid 12066519)
5. Chang YC, Yang SF, Tai KW, Chou MY, Hsieh YS. (2002). Increased tissue inhibitor of metalloproteinase-1 expression and inhibition of gelatinase: A activity in buccal mucosal fibroblasts by arecoline as possible mechanisms for oral submucous fibrosis. Oral Oncol 38:195-200.
6. Chaudhary AK, Pandya S, Mehrotra R, Bharti AC, Jain S, Singh M. (2010). Functional polymorphism of the MMP-1 promoter (-16071G/2G) in potentially malignant and malignant head and neck lesions in an Indian population. Biomarkers 15:684-692.
7. Chaudhary AK, Pandya S, Mehrotra R, Bharti AC, Singh M, Singh M. (2010). Comparative study between the Hybrid Capture II test and PCR based assay for the detection of human papillomavirus DNA in oral submucous fibrosis and oral squamous cell carcinoma. Virol J 7:253.
8. Chaudhary AK, Singh M, Bharti AC, Asotra K, Sundaram S, Mehrotra R. (2010). Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck. J Biomed Sci 17:10.
9. Chaudhary AK, Singh M, Bharti AC, Singh M, Shukla S, Singh AK, Mehrotra R. (2010). Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesions. BMC Cancer 10:369.
10. Chaudhary AK, Singh M, Sundaram S, Mehrotra R. (2009). Role of human papillomavirus and its detection in potentially malignant and malignant head and neck lesions: updated review. Head Neck Oncol 1:22.
11. Deryugina EI, Quigley JP. (2006). Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25:9-34. (Pubitemid 43723979)
12. Egeblad M, Werb Z. (2002). New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161-174. (Pubitemid 37328786)
13. Elander N, Söderkvist P, Fransén K. (2006). Matrix metalloproteinase (MMP) -1, -2, -3 and -9 promoter polymorphisms in colorectal cancer. Anticancer Res 26:791-795. (Pubitemid 43206050)
14. Franchi A, Santucci M, Masini E, Sardi I, Paglierani M, Gallo O. (2002). Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck. Cancer 95:1902-1910.
15. Grieu F, Li WQ, Iacopetta B. (2004). Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype. Breast Cancer Res Treat 88:197-204. (Pubitemid 40137297)
16. Ito I, Nagai S, Handa T, Muro S, Hirai T, Tsukino M, Mishima M. (2005). Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema. Am J Respir Crit Care Med 172:1378-1382. (Pubitemid 43069810)
17. Kawamata H, Nakashiro K, Uchida D, Harada K, Yoshida H, Sato M. (1997). Possible contribution of active MMP2 to lymph-node metastasis and secreted cathepsin L to bone invasion of newly established human oral-squamous-cancer cell lines. Int J Cancer 70:120-127. (Pubitemid 27059715)
18. Kawamata H, Uchida D, Hamano H, Kimura-Yanagawa T, Nakashiro KI, Hino S, Omotehara F, Yoshida H, Sato M. (1998). Active-MMP2 in cancer cell nests of oral cancer patients: correlation with lymph node metastasis. Int J Oncol 13:699-704. (Pubitemid 28435345)
19. Ko SY, Lin SC, Chang KW, Liu CJ, Chang SS, Lu SY, Liu TY. (2003). Modulation of KGF-1 gene expression in oral fibroblasts by ripe areca nut extract. J Oral Pathol Med 32:399-407.
20. Kurahara S, Shinohara M, Ikebe T, Nakamura S, Beppu M, Hiraki A, Takeuchi H, Shirasuna K. (1999). Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis. Head Neck 21:627-638. (Pubitemid 29459868)
21. Kusukawa J, Sasaguri Y, Shima I, Kameyama T, Morimatsu M. (1993). Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. A clinicopathologic study. Am J Clin Pathol 99:18-23. (Pubitemid 23030665)
22. Lei H, Hemminki K, Altieri A, Johansson R, Enquist K, Hallmans G, Lenner P, Försti A. (2007). Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression. Breast Cancer Res Treat 103:61-69. (Pubitemid 46653260)
23. Lichtinghagen R, Bahr MJ, Wehmeier M, Michels D, Haberkorn CI, Arndt B, Flemming P, Manns MP, Boeker KH. (2003). Expression and coordinated regulation of matrix metalloproteinases in chronic hepatitis C and hepatitis C virus-induced liver cirrhosis. Clin Sci 105:373-382. (Pubitemid 37088577)
24. Lin SC, Chen YJ, Kao SY, Hsu MT, Lin CH, Yang SC, Liu TY, Chang KW. (2002). Chromosomal changes in betel-associated oral squamous cell carcinomas and their relationship to clinical parameters. Oral Oncol 38:266-273. (Pubitemid 34442548)
25. Lin SC, Chung MY, Huang JW, Shieh TM, Liu CJ, Chang KW. (2004). Correlation between functional genotypes in the matrix metalloproteinases-1 promoter and risk of oral squamous cell carcinomas. J Oral Pathol Med 33:323-326.
26. Lin SC, Liu CJ, Yeh WI, Lui MT, Chang KW, Chang CS. (2006). Functional polymorphism in NFKB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers. Cancer Lett 243:47-54.
27. Lin SC, Lo SS, Liu CJ, Chung MY, Huang JW, Chang KW. (2004). Functional genotype in matrix metalloproteinases-2 promoter is a risk factor for oral carcinogenesis. J Oral Pathol Med 33:405-409.
28. Matsumura S, Oue N, Nakayama H, Kitadai Y, Yoshida K, Yamaguchi Y, Imai K, Nakachi K, Matsusaki K, Chayama K, Yasui W. (2005). A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer. J Cancer Res Clin Oncol 131:19-25.
29. Medley TL, Cole TJ, Dart AM, Gatzka CD, Kingwell BA. (2004). Matrix metalloproteinase-9 genotype influences large artery stiffness through effects on aortic gene and protein expression. Arterioscler Thromb Vasc Biol 24:1479-1484. (Pubitemid 39050444)
30. Mehrotra R, Chaudhary AK, Pandya S, Debnath S, Singh M, Singh M. (2010). Correlation of addictive factors, human papilloma virus infection and histopathology of oral submucous fibrosis. J Oral Pathol Med 39:460-464.
31. Mehrotra R, Pandya S, Chaudhary AK, Kumar M, Singh M. (2008). Prevalence of oral pre-malignant and malignant lesions at a tertiary level hospital in Allahabad, India. Asian Pac J Cancer Prev 9:263-265.
32. Miao X, Yu C, Tan W, Xiong P, Liang G, Lu W, Lin D. (2003). A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma. Cancer Res 63:3987-3990. (Pubitemid 36917916)
33. Mignatti P, Rifkin DB. (1993). Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73:161-195. (Pubitemid 23065437)
34. Morgan AR, Zhang B, Tapper W, Collins A, Ye S. (2003). Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease. J Mol Med 81:321-326. (Pubitemid 36718329)
35. Nagase H, Woessner JF Jr. (1999). Matrix metalloproteinases. J Biol Chem 274:21491-21494. (Pubitemid 129519680)
36. Okamoto K, Mimura K, Murawaki Y, Yuasa I. (2005). Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease. J Gastroenterol Hepatol 20:1102-1108. (Pubitemid 40961235)
37. Pandya S, Chaudhary AK, Singh M, Singh M, Mehrotra R. (2009). Correlation of histopathological diagnosis with habits and clinical findings in oral submucous fibrosis. Head Neck Oncol 1:10.
38. Patel SG, Shah JP. (2005). TNM staging of cancers of the head and neck: striving for uniformity among diversity. CA Cancer J Clin 55:242-58; quiz 261.
39. Pindborg JJ, Sirsat SM. (1966). Oral submucous fibrosis. Oral Surg Oral Med Oral Pathol 22:764-779.
40. Price SJ, Greaves DR, Watkins H. (2001). Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J Biol Chem 276:7549-7558.
41. Qin H, Sun Y, Benveniste EN. (1999). The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J Biol Chem 274:29130-29137.
42. Rajalalitha P, Vali S. (2005). Molecular pathogenesis of oral submucous fibrosis - a collagen metabolic disorder. J Oral Pathol Med 34:321-328. (Pubitemid 40868401)
43. Roehe AV, Frazzon AP, Agnes G, Damin AP, Hartman AA, Graudenz MS. (2007). Detection of polymorphisms in the promoters of matrix metalloproteinases 2 and 9 genes in breast cancer in South Brazil: preliminary results. Breast Cancer Res Treat 102:123-124. (Pubitemid 46294954)
44. Shieh TY, Yang JF. (1992). Collagenase activity in oral submucous fibrosis. Proc Natl Sci Counc Repub China B 16:106-110.
45. Tu HF, Wu CH, Kao SY, Liu CJ, Liu TY, Lui MT. (2007). Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users. J Oral Pathol Med 36:409-414. (Pubitemid 47037907)
46. Vairaktaris E, Vassiliou S, Nkenke E, Serefoglou Z, Derka S, Tsigris C, Vylliotis A, Yapijakis C, Neukam FW, Patsouris E. (2008). A metalloproteinase-9 polymorphism which affects its expression is associated with increased risk for oral squamous cell carcinoma. Eur J Surg Oncol 34:450-455. (Pubitemid 351391904)
47. Visse R, Nagase H. (2003). Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92:827-839. (Pubitemid 36542523)
48. Wagenaar-Miller RA, Gorden L, Matrisian LM. (2004). Matrix metalloproteinases in colorectal cancer: is it worth talking about? Cancer Metastasis Rev 23:119-135. (Pubitemid 38221599)
49. Westermarck J, Kähäri VM. (1999). Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13:781-792. (Pubitemid 29220691)
50. Woo M, Park K, Nam J, Kim JC. (2007). Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer. J Gastroenterol Hepatol 22:1064-1070. (Pubitemid 47019841)
51. Xing LL, Wang ZN, Jiang L, Zhang Y, Xu YY, Li J, Luo Y, Zhang X. (2007). Matrix metalloproteinase-9-1562C>T polymorphism may increase the risk of lymphatic metastasis of colorectal cancer. World J Gastroenterol 13:4626-4629.
52. Xu E, Xia X, Lü B, Xing X, Huang Q, Ma Y, Wang W, Lai M. (2007). Association of matrix metalloproteinase-2 and -9 promoter polymorphisms with colorectal cancer in Chinese. Mol Carcinog 46:924-929. (Pubitemid 350058412)
53. Xu EP, Huang Q, Lu BJ, Xing XM, Lai MD. (2006). The correlation between polymorphisms of matrix metalloproteinase-2 and -9 genes and colorectal cancer of Chinese patients. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 23:78-81. (Pubitemid 43241940)
54. Ye S. (2000). Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases. Matrix Biol 19:623-629.
55. Yorioka CW, Coletta RD, Alves F, Nishimoto IN, Kowalski LP, Graner E. (2002). Matrix metalloproteinase-2 and -9 activities correlate with the disease-free survival of oral squamous cell carcinoma patients. Int J Oncol 20:189-194.
56. Yoshizaki T, Maruyama Y, Sato H, Furukawa M. (2001). Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma. Int J Cancer 95:44-50.
57. Yu C, Pan K, Xing D, Liang G, Tan W, Zhang L, Lin D. (2002). Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer. Cancer Res 62:6430-6433. (Pubitemid 35364100)
58. Zhang B, Henney A, Eriksson P, Hamsten A, Watkins H, Ye S. (1999). Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1. Hum Genet 105:418-423.
59. Zhou Y, Yu C, Miao X, Wang Y, Tan W, Sun T, Zhang X, Xiong P, Lin D. (2005). Functional haplotypes in the promoter of matrix metalloproteinase- 2 and lung cancer susceptibility. Carcinogenesis 26:1117-1121. (Pubitemid 41214305)